Back to Search Start Over

A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC).

Authors :
Tai WM
Yong WP
Lim C
Low LS
Tham CK
Koh TS
Ng QS
Wang WW
Wang LZ
Hartono S
Thng CH
Huynh H
Lim KT
Toh HC
Goh BC
Choo SP
Source :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Feb 01; Vol. 29 (2), pp. 526.
Publication Year :
2018

Details

Language :
English
ISSN :
1569-8041
Volume :
29
Issue :
2
Database :
MEDLINE
Journal :
Annals of oncology : official journal of the European Society for Medical Oncology
Publication Type :
Academic Journal
Accession number :
28368515
Full Text :
https://doi.org/10.1093/annonc/mdx060